Protective and Dysregulated T Cell Immunity in RSV Infection

Overview

Journal Curr Opin Virol

Publisher Elsevier

Specialty Microbiology

Date 2013 Jun 29

PMID 23806514

Citations 68

Authors

Peter J Openshaw

Christopher Chiu

Affiliations

Soon will be listed here.

Abstract

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and a major pathogen in elderly and immunosuppressed persons. Although RSV shows limited antigenic diversity, repeated infections occur throughout life. Vaccine development has been delayed by poor immunogenicity, production issues and the fear of causing enhanced disease. T cells assist in viral clearance, but immune regulation serves to limit these responses and to prevent the exaggerated inflammatory response to RSV infection seen in children with bronchiolitis. Severe RSV disease can therefore be regarded as a dysregulated response to an otherwise trivial infection. Further insights into the role of T cells (including Th17) are needed to enable the rational design of safe, effective vaccines and novel treatments.

Citing Articles

Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.

Hsiung K, Chiang H, Reinig S, Shih S Vaccines (Basel). 2025; 12(12.

PMID: 39772007 PMC: 11679499. DOI: 10.3390/vaccines12121345.

Inhibiting retinoic acid signaling in dendritic cells suppresses respiratory syncytial virus infection through enhanced antiviral immunity.

Farazuddin M, Acker G, Zourob J, OKonek J, Wong P, Morris S iScience. 2024; 27(7):110103.

PMID: 39045100 PMC: 11263793. DOI: 10.1016/j.isci.2024.110103.

Nasopharyngeal and Peripheral Blood Type II Interferon Signature Evaluation in Infants during Respiratory Syncytial Virus Infection.

Savino F, Dini M, Clemente A, Calvi C, Pau A, Galliano I Medicina (Kaunas). 2024; 60(2).

PMID: 38399546 PMC: 10890591. DOI: 10.3390/medicina60020259.

Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model.

Eberlein V, Ahrends M, Bayer L, Finkensieper J, Besecke J, Mansuroglu Y Viruses. 2023; 15(9).

PMID: 37766253 PMC: 10535182. DOI: 10.3390/v15091846.

Human T cells efficiently control RSV infection.

De C, Pickles R, Yao W, Liao B, Boone A, Choi M JCI Insight. 2023; 8(11).

PMID: 37159271 PMC: 10393221. DOI: 10.1172/jci.insight.168110.

References

Schauer U, Hoffjan S, Rothoeft T, Bartz H, Konig S, Fuchs E . Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro. Clin Exp Immunol. 2004; 138(1):102-9. PMC: 1809175. DOI: 10.1111/j.1365-2249.2004.02582.x. View

Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, Peeples M . Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol. 2005; 34(3):320-9. PMC: 2644197. DOI: 10.1165/rcmb.2005-0287OC. View

Castro M, Schweiger T, Yin-DeClue H, Ramkumar T, Christie C, Zheng J . Cytokine response after severe respiratory syncytial virus bronchiolitis in early life. J Allergy Clin Immunol. 2008; 122(4):726-733.e3. PMC: 2597800. DOI: 10.1016/j.jaci.2008.07.010. View

Srikiatkhachorn A, Chang W, Braciale T . Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J Virol. 1999; 73(8):6590-7. PMC: 112743. DOI: 10.1128/JVI.73.8.6590-6597.1999. View

Sun J, Cardani A, Sharma A, Laubach V, Jack R, Muller W . Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog. 2011; 7(8):e1002173. PMC: 3150291. DOI: 10.1371/journal.ppat.1002173. View

Openshaw P, Clarke S, Record F . Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol. 1992; 4(4):493-500. DOI: 10.1093/intimm/4.4.493. View

Legg J, Hussain I, Warner J, Johnston S, Warner J . Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003; 168(6):633-9. DOI: 10.1164/rccm.200210-1148OC. View

Walsh E, Peterson D, Kalkanoglu A, Lee F, Falsey A . Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis. 2013; 207(9):1424-32. PMC: 3610422. DOI: 10.1093/infdis/jit038. View

Faber T, Groen H, Welfing M, Jansen K, Bont L . Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J Med Virol. 2012; 84(7):1084-8. DOI: 10.1002/jmv.23291. View

10.

Tregoning J, Wang B, McDonald J, Yamaguchi Y, Harker J, Goritzka M . Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proc Natl Acad Sci U S A. 2013; 110(14):5576-81. PMC: 3619373. DOI: 10.1073/pnas.1214247110. View

11.

Bera M, Lu B, Martin T, Cui S, Rhein L, Gerard C . Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol. 2011; 187(8):4245-55. PMC: 3186836. DOI: 10.4049/jimmunol.1101789. View

12.

Spann K, Tran K, Chi B, Rabin R, Collins P . Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol. 2004; 78(8):4363-9. PMC: 374276. DOI: 10.1128/jvi.78.8.4363-4369.2004. View

13.

Chi B, Dickensheets H, Spann K, Alston M, Luongo C, Dumoutier L . Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol. 2006; 80(10):5032-40. PMC: 1472058. DOI: 10.1128/JVI.80.10.5032-5040.2006. View

14.

Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster K, Sprent J . Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012; 5(2):161-72. PMC: 3282434. DOI: 10.1038/mi.2011.62. View

15.

Wythe S, Dodd J, Openshaw P, Schwarze J . OX40 ligand and programmed cell death 1 ligand 2 expression on inflammatory dendritic cells regulates CD4 T cell cytokine production in the lung during viral disease. J Immunol. 2012; 188(4):1647-55. PMC: 3276844. DOI: 10.4049/jimmunol.1103001. View

16.

Chang J, Srikiatkhachorn A, Braciale T . Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J Immunol. 2001; 167(8):4254-60. DOI: 10.4049/jimmunol.167.8.4254. View

17.

Gonzalez P, Prado C, Leiva E, Carreno L, Bueno S, Riedel C . Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A. 2008; 105(39):14999-5004. PMC: 2567482. DOI: 10.1073/pnas.0802555105. View

18.

Telcian A, Laza-Stanca V, Edwards M, Harker J, Wang H, Bartlett N . RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis. 2010; 203(1):85-94. PMC: 3086441. DOI: 10.1093/infdis/jiq020. View

19.

Falsey A, Singh H, Walsh E . Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol. 2006; 78(11):1493-7. DOI: 10.1002/jmv.20724. View

20.

Prince G, Curtis S, Yim K, Porter D . Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J Gen Virol. 2001; 82(Pt 12):2881-2888. DOI: 10.1099/0022-1317-82-12-2881. View